Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 317-331 , April 2009

Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice

  • Xue Jiang

      Affiliations

    • Department of Psychiatry and Behavior Sciences, University of Texas Medical Branch, Galveston, TX, USA
    • Chongqing University of Medical Sciences, Chongqing, China
    • ,
  • Jing Wang

      Affiliations

    • Department of Psychiatry and Behavior Sciences, University of Texas Medical Branch, Galveston, TX, USA
    • ,
  • Tian Luo

      Affiliations

    • Department of Psychiatry and Behavior Sciences, University of Texas Medical Branch, Galveston, TX, USA
    • ,
  • Qian Li

      Affiliations

    • Department of Psychiatry and Behavior Sciences, University of Texas Medical Branch, Galveston, TX, USA
    • Higuchi Biosciences Center, Department of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, USA
    • Corresponding Author InformationCorresponding author at: Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, 5044 Malott Hall, Lawrence, KS 66045, United States. Tel.: +1 785 864 3941.

Received 17 January 2008 ,Revised 12 September 2008 ,Accepted 17 September 2008.

References 

  1. Aguilera G, Jessop DS, Harbuz MS, Kiss A, Lightman SL. Differential regulation of hypothalamic pituitary corticotropin releasing hormone receptors during development of adjuvant-induced arthritis in the rat. J. Endocrinol. 1997;153:185–191
  2. Aguilera G, Rabadan-Diehl C, Nikodemova M. Regulation of pituitary corticotropin releasing hormone receptors. Peptides. 2001;22:769–774
  3. Ahrens T, Deuschle M, Krumm B, Van Der PG, den Boer JA, Lederbogen F. Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom. Med. 2008;
  4. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“ecstasy”) in serotonin transporter-deficient mice. Mol. Pharmacol. 1998;53:649–655
  5. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 2008;
  6. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389
  7. Dayas CV, Buller KM, Crane JW, Xu Y, Day TA. Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci. 2001;14:1143–1152
  8. Dijkstra I, Tilders FJH, Aguilera G, Kiss A, Rabadan-Diehl C, Barden N, et al. Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. J. Neurosci. 1998;18:3909–3918
  9. Fernald LC, Burke HM, Gunnar MR. Salivary cortisol levels in children of low-income women with high depressive symptomatology. Dev. Psychopathol. 2008;20:423–436
  10. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet. 1999;88:83–87
  11. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L, et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology. 2003;28:1031–1044
  12. Holmes A, Li Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2003;2:365–380
  13. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry. 2003;54:953–959
  14. Holmes A, Parmigiani S, Ferrari PF, Palanza P, Rodgers RJ. Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol. Behav. 2000;71:509–516
  15. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT1A receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology. 2003;28:2077–2088
  16. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin. Exp. Res. 2005;29:8–16
  17. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 2006;78:815–826
  18. Jabbi M, Korf J, Kema IP, Hartman C, Van Der PG, Minderaa RB, et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol. Psychiatry. 2007;12:483–490
  19. Kalueff AV, Ren-Patterson RF, Murphy DL. The developing use of heterozygous mutant mouse models in brain monoamine transporter research. Trends Pharmacol. Sci. 2007;28:122–127
  20. Kovacs KJ, Foldes A, Sawchenko PE. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J. Neurosci. 2000;20:3843–3852
  21. Kovacs KJ, Sawchenko PE. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 1996;16:262–273
  22. Lanfumey L, La Cour CM, Froger N, Hamon M. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem. Res. 2000;25:1199–1206
  23. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531
  24. Li Q. Cellular and molecular alterations in mice with deficient and reduced serotonin transporters. Mol. Neurobiol. 2006;34:51–66
  25. Li Q, Holmes A, Ma L, Van de Kar LD, Garcia F, Murphy DL. Medial hypothalamic 5-hydroxytryptamine (5-HT)1A receptors regulate neuroendocrine responses to stress and exploratory locomotor activity: application of recombinant adenovirus containing 5-HT1A sequences. J. Neurosci. 2004;24:10868–10877
  26. Li Q, Wichems C, Heils A, Lesch KP, Murphy DL. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: Gender and brain region differences. J. Neurosci. 2000;20:7888–7895
  27. Li Q, Wichems C, Heils A, Van de Kar LD, Lesch KP, Murphy DL. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J. Pharmacol. Exp. Ther. 1999;291:999–1007
  28. Lightman SL. The neuroendocrinology of stress: a never ending story. J. Neuroendocrinol. 2008;20:880–884
  29. Luo X, Kiss A, Rabadan-Diehl C, Aguilera G. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids. Endocrinology. 1995;136:3877–3883
  30. Murphy DL, Lerner A, Rudnick G, Lesch KP. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interventions. 2004;4:109–123
  31. Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008;9:85–96
  32. Murphy DL, Wichems C, Li Q, Heils A. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends Pharmacol. Sci. 1999;20:246–252
  33. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry. 2000;5:32–38
  34. Nikodemova M, Diehl CR, Aguilera G. Multiple sites of control of type-1 corticotropin releasing hormone receptor levels in the pituitary. Arch. Physiol. Biochem. 2002;110:123–128
  35. Pace TW, Spencer RL. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor. Am. J. Physiol. Endocrinol. Metab. 2005;288:E1082–E1088
  36. Pattyn F, Robbrecht P, De PA, Speleman F, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database, major update 2006. Nucleic Acids Res. 2006;34:D684–D688
  37. Pattyn F, Speleman F, De PA, Vandesompele J. RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res. 2003;31:122–123
  38. Paxinos G, Franklin KBJ. The Mouse Brain in Stereotaxic Coordinates. Academic Press Inc.; 2001;
  39. Penninx BW, Beekman AT, Bandinelli S, Corsi AM, Bremmer M, Hoogendijk WJ, et al. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am. J. Geriatr. Psychiatry. 2007;15:522–529
  40. Rabadan-Diehl C, Kiss A, Camacho C, Aguilera G. Regulation of messenger ribonucleic acid for corticotropin releasing hormone receptor in the pituitary during stress. Endocrinology. 1996;137:3808–3814
  41. Rabadan-Diehl C, Makara G, Kiss A, Zelena D, Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptor mRNA and CRH binding during adrenalectomy: role of glucocorticoids and hypothalamic factors. J. Neuroendocrinol. 1997;9:689–697
  42. Rodgers RJ, Cao BJ, Dalvi A, Holmes A. Animal models of anxiety: an ethological perspective. Brazilian J. Med. Biol. Res. 1997;30:289–304
  43. Rominger DH, Rominger CM, Fitzgerald LW, GRZANNA R, Largent BL, Zaczek R. Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies. J. Pharmacol. Exp. Ther. 1998;286:459–468
  44. Roy A, Hu XZ, Janal MN, Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology. 2007;32:2046–2052
  45. Schmidt M, Oitzl MS, Muller MB, Ohl F, Wurst W, Holsboer F, et al. Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice. Neuroscience. 2003;119:589–595
  46. Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol. 2005;26:139–162
  47. Tjurmina OA, Armando I, Saavedra JM, Li Q, Murphy DL. Life-long serotonin reuptake deficiency results in complex alterations in adrenomedullary responses to stress. Ann. N. Y. Acad. Sci. 2004;1018:99–104
  48. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034
  49. Weaver IC, Cervoni N, Champagne FA, D’Alessio AC, Sharma S, Seckl JR, et al. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004;7:847–854
  50. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, et al. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J. Neurosci. 2005;25:11045–11054
  51. Weaver IC, D’Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, et al. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J. Neurosci. 2007;27:1756–1768
  52. Weaver IC, Szyf M, Meaney MJ. From maternal care to gene expression: DNA methylation and the maternal programming of stress responses. Endocr. Res. 2002;28:699
  53. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry. 2006;163:1588–1593

PII: S0306-4530(08)00252-7

doi: 10.1016/j.psyneuen.2008.09.011

Psychoneuroendocrinology
Volume 34, Issue 3 , Pages 317-331 , April 2009

Article Tools

* Image Usage & Resolution